These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 9566460)
1. Economics, pharmaceuticals, and pharmacoeconomics. Johannesson M; O'Brien BJ Med Decis Making; 1998; 18(2 Suppl):S1-3. PubMed ID: 9566460 [No Abstract] [Full Text] [Related]
2. Pharmacoeconomics comes of age? Walley T; Breckenridge A Clin Pharmacol Ther; 2008 Aug; 84(2):279-80. PubMed ID: 18563057 [TBL] [Abstract][Full Text] [Related]
3. Science, pharmacoeconomics and ethics in drug R&D: a sustainable future scenario? Preziosi P Nat Rev Drug Discov; 2004 Jun; 3(6):521-6. PubMed ID: 15173841 [No Abstract] [Full Text] [Related]
4. Drug therapy: safety, effectiveness, and economics. Brandys J Przegl Lek; 2001; 58(4):226-8. PubMed ID: 11450340 [TBL] [Abstract][Full Text] [Related]
5. The role of colleges of pharmacy in meeting the pharmacoeconomic needs of the pharmaceutical industry: a conference report. Draugalis JR; Coons SJ Clin Ther; 1994; 16(3):523-37; discussion 522. PubMed ID: 7923318 [TBL] [Abstract][Full Text] [Related]
6. Pharmacoeconomics: the new dismal science. Luchins DJ Adm Policy Ment Health; 2004 May; 31(5):425-7. PubMed ID: 15379388 [No Abstract] [Full Text] [Related]
7. Pharmacoeconomics in the new millennium. A pharmaceutical industry perspective. Thwaites R; Townsend RJ Pharmacoeconomics; 1998 Feb; 13(2):175-80. PubMed ID: 10178645 [TBL] [Abstract][Full Text] [Related]
8. Rising drug prices drive US manufacturers' revenues, analysis finds. McCarthy M BMJ; 2015 Oct; 351():h5376. PubMed ID: 26446098 [No Abstract] [Full Text] [Related]
9. [Pharmacoeconomics--survey and status]. Pedersen KM Ugeskr Laeger; 2003 Apr; 165(16):1670-4. PubMed ID: 12756827 [TBL] [Abstract][Full Text] [Related]
10. Medicine, pharmacy, and industry--a fly's eye view of health care. Halperin JA Ann Pharmacother; 1995 Sep; 29(9):925-33. PubMed ID: 8547743 [No Abstract] [Full Text] [Related]
12. No immediate pain relief for the pharmaceutical industry. Ahlborn H; Henderson S; Davies N Curr Opin Drug Discov Devel; 2005 May; 8(3):384-91. PubMed ID: 15892254 [TBL] [Abstract][Full Text] [Related]
13. Will lower drug prices jeopardize drug research? A policy fact sheet. Light DW; Lexchin J Am J Bioeth; 2004; 4(1):W1-4. PubMed ID: 15035915 [No Abstract] [Full Text] [Related]
14. Acquisitions not a cure for anti-infectives. Bradley D Nat Rev Drug Discov; 2005 Sep; 4(9):704-5. PubMed ID: 16178116 [No Abstract] [Full Text] [Related]
15. Indian generics companies go on spending spree. Jayaraman KS Nat Rev Drug Discov; 2005 Aug; 4(8):616-7. PubMed ID: 16106583 [No Abstract] [Full Text] [Related]
16. The pharmacoeconomics of spiralling cancer drug costs - is there a viable solution? Alifrangis C; Krell J; Stebbing J Eur J Cancer; 2011 Jun; 47(9):1285-6. PubMed ID: 21550231 [No Abstract] [Full Text] [Related]
17. [PHARMACEUTICAL economics and problems]. Gaz Med Fr; 1959 Sep; 66():1349-50. PubMed ID: 13857100 [No Abstract] [Full Text] [Related]
18. Pharmacoeconomics in South Africa. Jones JS S Afr Med J; 2006 Feb; 96(2):96. PubMed ID: 16541546 [No Abstract] [Full Text] [Related]